References
- Zeymer U., Schroder K., Wegscheider K., Senges J., Neuhaus K. L., Schroder R. ST resolution in a single electrocardiographic lead: a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST‐elevation myocardial infarction. Am Heart J 2005; 149: 91–7
- Bjorklund E., Lindahl B., Johanson P., Jernberg T., Svensson A. M., Venge B., et al. Admission Troponin T and measurement of ST‐segment resolution at 60 min improve early risk stratification in ST‐elevation myocardial infarction. Eur Heart J 2004; 25: 113–20
- Boldt H. B., Overgaard M. T., Laursen L. S., Weyer K., Sottrup‐Jensen L., Oxvig C. Mutational analysis of the proteolytic domain of pregnancy‐associated plasma protein‐A (PAPP‐A): classification as a metzincin. Biochem J 2001; 358: 359–67
- Bayes‐Genis A., Conover C. A., Overgaard M. T., Bailey K. R., Christiansen M., Holmes D. R., et al. Pregnancy‐associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001; 345: 1022–9
- Cosin‐Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M. T., Cole D., et al. Pregnancy‐associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004; 109: 1724–8
- Lund J., Qin Q. P., Ilva T., Pettersson K., Voipio‐Pulkki L‐M., Porela P., et al. Circulating pregnancy‐associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003; 108: 1924–6
- Laterza O. F., Cameron S. J., Chappell D., Sokoll L. J., Green G. B. Evaluation of pregnancy‐associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clinica Chimica Acta 2004; 384: 163–9
- Heeschen C., Dimmeler S., Hamm C. W., Fichtlscherer S., Simoons M. L., Zeiher A. M., et al. Pregnancy‐associated plasma protein‐A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005; 45: 229–37
- Qin Q. P., Laitinen P., Majamaa‐Voltti K., Eriksson S., Kumpula E‐K., Pettersson K. Release patterns of pregnancy associated plasma protein A (PAPP‐A) in patients with acute coronary syndromes. Scand Cardiovasc J 2002; 36: 358–61
- Qin Q. P., Christiansen M., Pettersson K. Point‐of‐care time‐resolved immunofluorometric assay for human pregnancy‐associated plasma protein A: use in first‐trimester screening for Down syndrome. Clin Chem 2002; 48: 473–83
- Qin Q. P., Kokkala S., Lund J., Tamm N., Voipio‐Pulkki L‐M., Pettersson K. Molecular distinction of circulating pregnancy associated plasma protein‐A in myocardial infarction and pregnancy. Clin Chem 2005; 51: 75–83